{"id":357191,"date":"2025-08-29T10:07:29","date_gmt":"2025-08-29T10:07:29","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-rapport-therapeutics\/"},"modified":"2025-08-29T10:07:29","modified_gmt":"2025-08-29T10:07:29","slug":"how-to-buy-rapport-therapeutics","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-rapport-therapeutics\/","title":{"rendered":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Rapport Therapeutics, Inc. (RAPP) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Rapport Therapeutics, Inc. (RAPP)"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334036,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-357191","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Rapport Therapeutics, Inc. (RAPP) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu Rapport Therapeutics, Inc. (RAPP)","h1_source":{"label":"H1","type":"text","formatted_value":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Rapport Therapeutics, Inc. (RAPP) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu Rapport Therapeutics, Inc. (RAPP)"},"description":"T\u00ecm hi\u1ec3u c\u00e1ch mua c\u1ed5 phi\u1ebfu Rapport Therapeutics (RAPP) v\u00e0 \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u0111\u1ea7y h\u1ee9a h\u1eb9n n\u00e0y. Kh\u00e1m ph\u00e1 gi\u00e1 hi\u1ec7n t\u1ea1i, r\u1ee7i ro v\u00e0 ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng cho giai \u0111o\u1ea1n 2025-2030.","description_source":{"label":"Description","type":"textarea","formatted_value":"T\u00ecm hi\u1ec3u c\u00e1ch mua c\u1ed5 phi\u1ebfu Rapport Therapeutics (RAPP) v\u00e0 \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u0111\u1ea7y h\u1ee9a h\u1eb9n n\u00e0y. Kh\u00e1m ph\u00e1 gi\u00e1 hi\u1ec7n t\u1ea1i, r\u1ee7i ro v\u00e0 ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng cho giai \u0111o\u1ea1n 2025-2030."},"intro":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c \u0111\u1ea7u t\u01b0 v\u00e0o c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u0111\u1ed9t ph\u00e1 ti\u1ebfp theo? Rapport Therapeutics (RAPP) \u0111\u1ea1i di\u1ec7n cho c\u00f4ng ngh\u1ec7 ti\u00ean ti\u1ebfn trong l\u0129nh v\u1ef1c th\u1ea7n kinh ch\u00ednh x\u00e1c \u2014 nh\u1eafm m\u1ee5c ti\u00eau c\u00e1c r\u1ed1i lo\u1ea1n n\u00e3o b\u1ed9 v\u1edbi \u0111\u1ed9 ch\u00ednh x\u00e1c c\u00e1ch m\u1ea1ng. V\u1edbi k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m Giai \u0111o\u1ea1n 2 s\u1ebd \u0111\u01b0\u1ee3c c\u00f4ng b\u1ed1 v\u00e0o th\u00e1ng 9 n\u0103m 2025, c\u1ed5 phi\u1ebfu n\u00e0y c\u00f3 th\u1ec3 s\u1eafp c\u00f3 bi\u1ebfn \u0111\u1ed9ng \u0111\u00e1ng k\u1ec3. Ch\u00fang t\u00f4i s\u1ebd ph\u00e2n t\u00edch m\u1ecdi th\u1ee9 t\u1eeb gi\u00e1 hi\u1ec7n t\u1ea1i \u0111\u1ebfn c\u00e1c chi\u1ebfn l\u01b0\u1ee3c mua c\u1ed5 phi\u1ebfu t\u1eebng b\u01b0\u1edbc.","intro_source":{"label":"Intro","type":"text","formatted_value":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c \u0111\u1ea7u t\u01b0 v\u00e0o c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u0111\u1ed9t ph\u00e1 ti\u1ebfp theo? Rapport Therapeutics (RAPP) \u0111\u1ea1i di\u1ec7n cho c\u00f4ng ngh\u1ec7 ti\u00ean ti\u1ebfn trong l\u0129nh v\u1ef1c th\u1ea7n kinh ch\u00ednh x\u00e1c \u2014 nh\u1eafm m\u1ee5c ti\u00eau c\u00e1c r\u1ed1i lo\u1ea1n n\u00e3o b\u1ed9 v\u1edbi \u0111\u1ed9 ch\u00ednh x\u00e1c c\u00e1ch m\u1ea1ng. V\u1edbi k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m Giai \u0111o\u1ea1n 2 s\u1ebd \u0111\u01b0\u1ee3c c\u00f4ng b\u1ed1 v\u00e0o th\u00e1ng 9 n\u0103m 2025, c\u1ed5 phi\u1ebfu n\u00e0y c\u00f3 th\u1ec3 s\u1eafp c\u00f3 bi\u1ebfn \u0111\u1ed9ng \u0111\u00e1ng k\u1ec3. Ch\u00fang t\u00f4i s\u1ebd ph\u00e2n t\u00edch m\u1ecdi th\u1ee9 t\u1eeb gi\u00e1 hi\u1ec7n t\u1ea1i \u0111\u1ebfn c\u00e1c chi\u1ebfn l\u01b0\u1ee3c mua c\u1ed5 phi\u1ebfu t\u1eebng b\u01b0\u1edbc."},"body_html":"<h2>\ud83d\udcc8 Gi\u00e1 C\u1ed5 Phi\u1ebfu Hi\u1ec7n T\u1ea1i v\u00e0 C\u00e1c Ng\u00e0y Quan Tr\u1ecdng<\/h2> <p>T\u00ednh \u0111\u1ebfn ng\u00e0y 29 th\u00e1ng 8 n\u0103m 2025, c\u1ed5 phi\u1ebfu Rapport Therapeutics (RAPP) giao d\u1ecbch \u1edf m\u1ee9c <strong>14,63 USD<\/strong> tr\u00ean NASDAQ. H\u00e3y \u0111\u00e1nh d\u1ea5u l\u1ecbch: <strong>Th\u00e1ng 9 n\u0103m 2025 l\u00e0 th\u1eddi \u0111i\u1ec3m c\u1ef1c k\u1ef3 quan tr\u1ecdng<\/strong> \u2014 \u0111\u00f3 l\u00e0 khi c\u00f4ng ty c\u00f4ng b\u1ed1 k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m Giai \u0111o\u1ea1n 2a cho thu\u1ed1c ch\u1ee7 l\u1ef1c RAP-219 trong \u0111i\u1ec1u tr\u1ecb \u0111\u1ed9ng kinh kh\u00e1ng thu\u1ed1c.<\/p> <p><strong>T\u1ea1i sao th\u00e1ng 9 l\u1ea1i quan tr\u1ecdng:<\/strong><br\/> L\u1ecbch s\u1eed cho th\u1ea5y c\u00e1c c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc th\u01b0\u1eddng c\u00f3 bi\u1ebfn \u0111\u1ed9ng gi\u00e1 l\u1edbn quanh c\u00e1c k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng. Khi Rapport c\u00f4ng b\u1ed1 k\u1ebft qu\u1ea3 qu\u00fd 2 v\u00e0o ng\u00e0y 7 th\u00e1ng 8 n\u0103m 2025, h\u1ecd \u0111\u00e3 v\u01b0\u1ee3t k\u1ef3 v\u1ecdng v\u1edbi m\u1ee9c l\u1ed7 0,75 USD tr\u00ean m\u1ed7i c\u1ed5 phi\u1ebfu so v\u1edbi m\u1ee9c l\u1ed7 d\u1ef1 ki\u1ebfn 0,85 USD (<a href=\"https:\/\/www.chartmill.com\/news\/RAPP\/Chartmill-32659-Rapport-Therapeutics-Inc-NASDAQRAPP-Reports-Narrower-Than-Expected-Q2-2025-Loss-Amid-Clinical-Progress\">Chartmill<\/a>). C\u1ed5 phi\u1ebfu t\u0103ng nh\u1eb9, nh\u01b0ng s\u1ef1 b\u00f9ng n\u1ed5 th\u1ef1c s\u1ef1 s\u1ebd \u0111\u1ebfn c\u00f9ng v\u1edbi d\u1eef li\u1ec7u th\u00e1ng 9.<\/p>  [cta_green text=\"B\u1eaft \u0111\u1ea7u giao d\u1ecbch\"]<h2>\ud83d\udcca H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng: T\u1eeb \u0110\u00e1y \u0110\u1ebfn Ph\u1ee5c H\u1ed3i<\/h2> <p>RAPP \u0111\u00e3 tr\u1ea3i qua m\u1ed9t chuy\u1ebfn t\u00e0u l\u01b0\u1ee3n si\u00eau t\u1ed1c! \u0110\u00e2y l\u00e0 nh\u1eefng g\u00ec \u0111\u00e3 x\u1ea3y ra trong 6 th\u00e1ng qua:<\/p> <p><strong>Th\u00e1ng 3 n\u0103m 2025:<\/strong> Ch\u1ea1m \u0111\u00e1y \u1edf m\u1ee9c <strong>6,43 USD<\/strong> \u2014 \u0111i\u1ec3m th\u1ea5p nh\u1ea5t tuy\u1ec7t \u0111\u1ed1i (<a href=\"https:\/\/www.tradingview.com\/symbols\/NASDAQ-RAPP\/\">TradingView<\/a>). Nh\u00e0 \u0111\u1ea7u t\u01b0 lo ng\u1ea1i v\u1ec1 vi\u1ec7c ti\u00eau ti\u1ec1n v\u00e0 ti\u1ebfn \u0111\u1ed9 th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng.<\/p> <p><strong>Th\u00e1ng 5-6 n\u0103m 2025:<\/strong> Ph\u1ee5c h\u1ed3i \u1ed5n \u0111\u1ecbnh l\u00ean kho\u1ea3ng <strong>8-12 USD<\/strong> khi c\u00f4ng ty c\u00f4ng b\u1ed1 d\u1eef li\u1ec7u an to\u00e0n Giai \u0111o\u1ea1n 1 t\u00edch c\u1ef1c v\u00e0 ti\u1ebfp t\u1ee5c tuy\u1ec3n d\u1ee5ng b\u1ec7nh nh\u00e2n th\u1eed nghi\u1ec7m.<\/p> <p><strong>Th\u00e1ng 8 n\u0103m 2025:<\/strong> \u1ed4n \u0111\u1ecbnh quanh m\u1ee9c <strong>14-16 USD<\/strong> sau k\u1ebft qu\u1ea3 qu\u00fd 2 t\u1ed1t h\u01a1n d\u1ef1 ki\u1ebfn v\u00e0 ho\u00e0n th\u00e0nh tuy\u1ec3n d\u1ee5ng th\u1eed nghi\u1ec7m Giai \u0111o\u1ea1n 2a.<\/p> <p><strong>Hi\u1ec7u su\u1ea5t 3 th\u00e1ng cho th\u1ea5y m\u1ee9c t\u0103ng \u1ea5n t\u01b0\u1ee3ng +34,26%<\/strong> (<a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/RAPP\/chart\/\">MarketBeat<\/a>), cho th\u1ea5y \u0111\u1ed9ng l\u1ef1c m\u1ea1nh m\u1ebd tr\u01b0\u1edbc s\u1ef1 ki\u1ec7n quan tr\u1ecdng th\u00e1ng 9.<\/p>  <h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2> <ul> <li><strong>2025 (Cu\u1ed1i n\u0103m): 19-22 USD<\/strong> - N\u1ebfu k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m th\u00e1ng 9 t\u00edch c\u1ef1c, gi\u00e1 c\u00f3 th\u1ec3 t\u0103ng nhanh. \u01af\u1edbc t\u00ednh th\u1eadn tr\u1ecdng n\u1ebfu k\u1ebft qu\u1ea3 h\u1ed7n h\u1ee3p.<\/li> <li><strong>2026: 25-30 USD<\/strong> - Gi\u1ea3 s\u1eed d\u1eef li\u1ec7u Giai \u0111o\u1ea1n 2 th\u00e0nh c\u00f4ng d\u1eabn \u0111\u1ebfn m\u1edf r\u1ed9ng th\u1eed nghi\u1ec7m v\u00e0 th\u1ea3o lu\u1eadn h\u1ee3p t\u00e1c ti\u1ec1m n\u0103ng.<\/li> <li><strong>2028: 40-50 USD<\/strong> - Th\u1eddi \u0111i\u1ec3m c\u00f3 th\u1ec3 \u0111\u01b0\u1ee3c FDA ph\u00ea duy\u1ec7t ch\u1ec9 \u0111\u1ecbnh ch\u00ednh, t\u1ea1o ra gi\u00e1 tr\u1ecb \u0111\u00e1ng k\u1ec3.<\/li> <li><strong>2030: Tr\u00ean 60 USD<\/strong> - Nhi\u1ec1u ch\u1ec9 \u0111\u1ecbnh \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t v\u00e0 c\u00f3 th\u1ec3 tr\u1edf th\u00e0nh m\u1ee5c ti\u00eau mua l\u1ea1i c\u1ee7a c\u00e1c c\u00f4ng ty d\u01b0\u1ee3c l\u1edbn h\u01a1n.<\/li> <\/ul> <p><strong>K\u1ebft lu\u1eadn: MUA M\u1ea0NH<\/strong> d\u00e0nh cho nh\u00e0 \u0111\u1ea7u t\u01b0 ch\u1ecbu r\u1ee7i ro. S\u1ef1 ki\u1ec7n th\u00e1ng 9 c\u00f3 th\u1ec3 mang t\u00ednh chuy\u1ec3n \u0111\u1ed5i.<\/p>  <h2>\u26a0\ufe0f R\u1ee7i Ro Ch\u00ednh v\u00e0 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2> <h3>R\u1ee7i ro c\u1ea7n c\u00e2n nh\u1eafc:<\/h3> <ul> <li><strong>Th\u1ea5t b\u1ea1i th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng<\/strong> - K\u1ebft qu\u1ea3 Giai \u0111o\u1ea1n 2 c\u00f3 th\u1ec3 g\u00e2y th\u1ea5t v\u1ecdng (gi\u1ea3m 40-50% c\u00f3 th\u1ec3 x\u1ea3y ra)<\/li> <li><strong>Ti\u00eau ti\u1ec1n nhanh<\/strong> - D\u1ef1 tr\u1eef ti\u1ec1n m\u1eb7t 260 tri\u1ec7u USD \u0111\u1ebfn n\u0103m 2026, nh\u01b0ng chi ph\u00ed R&D \u0111ang t\u0103ng<\/li> <li><strong>R\u00e0o c\u1ea3n ph\u00e1p l\u00fd<\/strong> - Qu\u00e1 tr\u00ecnh ph\u00ea duy\u1ec7t FDA kh\u00f4ng th\u1ec3 \u0111o\u00e1n tr\u01b0\u1edbc<\/li> <li><strong>C\u1ea1nh tranh<\/strong> - C\u00e1c c\u00f4ng ty kh\u00e1c nh\u1eafm v\u00e0o c\u00e1c b\u1ec7nh th\u1ea7n kinh t\u01b0\u01a1ng t\u1ef1<\/li> <\/ul> <h3>T\u00edn hi\u1ec7u t\u00edch c\u1ef1c cho n\u0103m 2025:<\/h3> <ul> <li><strong>S\u1ef1 ki\u1ec7n th\u00e1ng 9<\/strong> - K\u1ebft qu\u1ea3 Giai \u0111o\u1ea1n 2 c\u00f3 th\u1ec3 th\u00fac \u0111\u1ea9y l\u1ee3i nhu\u1eadn tr\u00ean 100%<\/li> <li><strong>H\u1ed3 s\u01a1 an to\u00e0n s\u1ea1ch<\/strong> - Kh\u00f4ng c\u00f3 s\u1ef1 ki\u1ec7n b\u1ea5t l\u1ee3i nghi\u00eam tr\u1ecdng trong Giai \u0111o\u1ea1n 1 (<a href=\"https:\/\/www.stocktitan.net\/news\/RAPP\/rapport-therapeutics-reports-second-quarter-2025-financials-and-3wf9w5qi8j45.html\">StockTitan<\/a>)<\/li> <li><strong>Nhi\u1ec1u ch\u1ec9 \u0111\u1ecbnh<\/strong> - C\u00e1c ch\u01b0\u01a1ng tr\u00ecnh \u0111i\u1ec1u tr\u1ecb \u0111\u1ed9ng kinh, h\u01b0ng c\u1ea3m l\u01b0\u1ee1ng c\u1ef1c v\u00e0 \u0111au th\u1ea7n kinh<\/li> <li><strong>H\u1ed7 tr\u1ee3 m\u1ea1nh t\u1eeb c\u00e1c nh\u00e0 ph\u00e2n t\u00edch<\/strong> - M\u1ee5c ti\u00eau gi\u00e1 trung b\u00ecnh 33,67 USD (t\u0103ng 102%)<\/li> <\/ul>  <h2>\ud83d\udee1\ufe0f Nh\u00e0 Giao D\u1ecbch M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2> <ol> <li><strong>B\u1eaft \u0111\u1ea7u nh\u1ecf<\/strong> - Ph\u00e2n b\u1ed5 kh\u00f4ng qu\u00e1 2-3% danh m\u1ee5c cho c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc r\u1ee7i ro cao<\/li> <li><strong>Ch\u1edd \u0111\u1ebfn th\u00e1ng 9<\/strong> - C\u00e2n nh\u1eafc mua sau khi c\u00f3 k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m \u0111\u1ec3 gi\u1ea3m r\u1ee7i ro<\/li> <li><strong>S\u1eed d\u1ee5ng l\u1ec7nh gi\u1edbi h\u1ea1n<\/strong> - \u0110\u1eb7t gi\u00e1 mua t\u1ed1i \u0111a \u0111\u1ec3 tr\u00e1nh tr\u1ea3 qu\u00e1 cao<\/li> <li><strong>G\u00f3c nh\u00ecn h\u00e0i h\u01b0\u1edbc<\/strong>: \"Giao d\u1ecbch RAPP gi\u1ed1ng nh\u01b0 h\u1eb9n h\u00f2 th\u1eddi trung h\u1ecdc \u2014 ti\u1ec1m n\u0103ng h\u1ed3i h\u1ed9p nh\u01b0ng h\u00e3y chu\u1ea9n b\u1ecb cho nh\u1eefng c\u00fa s\u1ed1c c\u1ea3m x\u00fac. Gi\u1eef tr\u00e1i tim v\u00e0 danh m\u1ee5c \u0111\u1ea7u t\u01b0 c\u1ee7a b\u1ea1n an to\u00e0n!\"<\/li> <\/ol>  <h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Rapport Therapeutics (RAPP) - T\u1eebng B\u01b0\u1edbc<\/h2> <table> <thead> <tr><th>B\u01b0\u1edbc<\/th><th>H\u00e0nh \u0110\u1ed9ng<\/th><th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Ch\u1ecdn n\u1ec1n t\u1ea3ng giao d\u1ecbch<\/td><td>\u0110\u1ea3m b\u1ea3o n\u1ec1n t\u1ea3ng cung c\u1ea5p c\u1ed5 phi\u1ebfu NASDAQ v\u00e0 ph\u00ed h\u1ee3p l\u00fd<\/td><\/tr> <tr><td>2<\/td><td>M\u1edf v\u00e0 n\u1ea1p ti\u1ec1n v\u00e0o t\u00e0i kho\u1ea3n<\/td><td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n b\u1ea1n c\u1ea3m th\u1ea5y tho\u1ea3i m\u00e1i khi r\u1ee7i ro<\/td><\/tr> <tr><td>3<\/td><td>T\u00ecm ki\u1ebfm \"RAPP\"<\/td><td>S\u1eed d\u1ee5ng m\u00e3 ch\u1ee9ng kho\u00e1n, kh\u00f4ng ch\u1ec9 t\u00ean c\u00f4ng ty<\/td><\/tr> <tr><td>4<\/td><td>\u0110\u1eb7t l\u1ec7nh gi\u1edbi h\u1ea1n<\/td><td>Ch\u1ec9 \u0111\u1ecbnh m\u1ee9c gi\u00e1 14,50 USD ho\u1eb7c th\u1ea5p h\u01a1n \u0111\u1ec3 c\u00f3 \u0111i\u1ec3m v\u00e0o t\u1ed1t<\/td><\/tr> <tr><td>5<\/td><td>Xem l\u1ea1i v\u00e0 x\u00e1c nh\u1eadn<\/td><td>Ki\u1ec3m tra ph\u00ed hoa h\u1ed3ng \u2014 m\u1ee5c ti\u00eau d\u01b0\u1edbi 1%<\/td><\/tr> <\/tbody> <\/table>  <h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option Ph\u00f9 H\u1ee3p V\u1edbi Nh\u00e0 \u0110\u1ea7u T\u01b0 M\u1edbi<\/h2> <p>Pocket Option gi\u00fap \u0111\u1ea7u t\u01b0 c\u1ed5 phi\u1ebfu tr\u1edf n\u00ean d\u1ec5 ti\u1ebfp c\u1eadn cho m\u1ecdi ng\u01b0\u1eddi:<\/p> <ul> <li><strong>S\u1ed1 ti\u1ec1n g\u1eedi t\u1ed1i thi\u1ec3u: 5 USD<\/strong> - Ho\u00e0n h\u1ea3o \u0111\u1ec3 th\u1eed nghi\u1ec7m chi\u1ebfn l\u01b0\u1ee3c v\u1edbi r\u1ee7i ro th\u1ea5p<\/li> <li><strong>X\u00e1c minh nhanh nh\u01b0 ch\u1edbp<\/strong> - T\u1ea3i l\u00ean b\u1ea5t k\u1ef3 gi\u1ea5y t\u1edd t\u00f9y th\u00e2n n\u00e0o v\u00e0 b\u1eaft \u0111\u1ea7u giao d\u1ecbch trong v\u00e0i ph\u00fat<\/li> <li><strong>H\u01a1n 100 l\u1ef1a ch\u1ecdn r\u00fat ti\u1ec1n<\/strong> - T\u1eeb ti\u1ec1n \u0111i\u1ec7n t\u1eed \u0111\u1ebfn v\u00ed \u0111i\u1ec7n t\u1eed v\u00e0 th\u1ebb ng\u00e2n h\u00e0ng<\/li> <\/ul> <p>Giao di\u1ec7n th\u00e2n thi\u1ec7n v\u1edbi ng\u01b0\u1eddi d\u00f9ng v\u00e0 t\u00e0i nguy\u00ean gi\u00e1o d\u1ee5c c\u1ee7a n\u1ec1n t\u1ea3ng l\u00e0m cho n\u00f3 l\u00fd t\u01b0\u1edfng cho ng\u01b0\u1eddi m\u1edbi b\u1eaft \u0111\u1ea7u mu\u1ed1n th\u1eed s\u1ee9c \u0111\u1ea7u t\u01b0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc m\u00e0 kh\u00f4ng b\u1ecb qu\u00e1 t\u1ea3i.<\/p>  <h2>\ud83c\udf0d Rapport Therapeutics N\u0103m 2025: Nh\u00e0 \u0110\u1ed5i M\u1edbi Trong L\u0129nh V\u1ef1c Th\u1ea7n Kinh<\/h2> <p>Rapport Therapeutics \u0111ang c\u00e1ch m\u1ea1ng h\u00f3a c\u00e1ch ch\u00fang ta \u0111i\u1ec1u tr\u1ecb c\u00e1c r\u1ed1i lo\u1ea1n n\u00e3o b\u1ed9. Kh\u00e1c v\u1edbi c\u00e1c lo\u1ea1i thu\u1ed1c truy\u1ec1n th\u1ed1ng \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn to\u00e0n b\u1ed9 n\u00e3o, c\u00f4ng ngh\u1ec7 RAP c\u1ee7a h\u1ecd nh\u1eafm v\u00e0o c\u00e1c v\u00f9ng c\u1ee5 th\u1ec3 \u2014 gi\u1ed1ng nh\u01b0 s\u1eed d\u1ee5ng s\u00fang b\u1eafn t\u1ec9a thay v\u00ec s\u00fang s\u0103n (<a href=\"https:\/\/www.globenewswire.com\/news-release\/2025\/06\/02\/3092291\/0\/en\/Rapport-Therapeutics-Hosts-Investor-and-Analyst-Day-Provides-Corporate-Updates.html\">GlobeNewswire<\/a>).<\/p> <p>Thu\u1ed1c ch\u1ee7 l\u1ef1c c\u1ee7a c\u00f4ng ty, RAP-219, \u0111\u00e3 ho\u00e0n th\u00e0nh tuy\u1ec3n d\u1ee5ng Giai \u0111o\u1ea1n 2a trong qu\u00fd 2 n\u0103m 2025 v\u00e0 c\u00f3 th\u1ec3 gi\u00fap h\u00e0ng tri\u1ec7u ng\u01b0\u1eddi m\u1eafc \u0111\u1ed9ng kinh kh\u00e1ng thu\u1ed1c. V\u1edbi 260,4 tri\u1ec7u USD ti\u1ec1n m\u1eb7t, h\u1ecd \u0111\u01b0\u1ee3c t\u00e0i tr\u1ee3 \u0111\u1ebfn n\u0103m 2026 \u2014 \u0111\u1ee7 ngu\u1ed3n l\u1ef1c \u0111\u1ec3 \u0111\u1ea1t c\u00e1c c\u1ed9t m\u1ed1c quan tr\u1ecdng.<\/p> <p><strong>S\u1ef1 th\u1eadt th\u00fa v\u1ecb:<\/strong> N\u0103m 2025, c\u00e1c nh\u00e0 khoa h\u1ecdc c\u1ee7a Rapport ph\u00e1t hi\u1ec7n c\u00f4ng ngh\u1ec7 c\u1ee7a h\u1ecd c\u00f3 th\u1ec3 \u0111\u01b0\u1ee3c \u00e1p d\u1ee5ng cho c\u00e1c r\u1ed1i lo\u1ea1n th\u00ednh gi\u00e1c, m\u1edf ra c\u00e1c h\u01b0\u1edbng \u0111i\u1ec1u tr\u1ecb ho\u00e0n to\u00e0n m\u1edbi ngo\u00e0i tr\u1ecdng t\u00e2m hi\u1ec7n t\u1ea1i v\u1ec1 \u0111\u1ed9ng kinh v\u00e0 \u0111au.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Gi\u00e1 C\u1ed5 Phi\u1ebfu Hi\u1ec7n T\u1ea1i v\u00e0 C\u00e1c Ng\u00e0y Quan Tr\u1ecdng<\/h2>\n<p>T\u00ednh \u0111\u1ebfn ng\u00e0y 29 th\u00e1ng 8 n\u0103m 2025, c\u1ed5 phi\u1ebfu Rapport Therapeutics (RAPP) giao d\u1ecbch \u1edf m\u1ee9c <strong>14,63 USD<\/strong> tr\u00ean NASDAQ. H\u00e3y \u0111\u00e1nh d\u1ea5u l\u1ecbch: <strong>Th\u00e1ng 9 n\u0103m 2025 l\u00e0 th\u1eddi \u0111i\u1ec3m c\u1ef1c k\u1ef3 quan tr\u1ecdng<\/strong> \u2014 \u0111\u00f3 l\u00e0 khi c\u00f4ng ty c\u00f4ng b\u1ed1 k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m Giai \u0111o\u1ea1n 2a cho thu\u1ed1c ch\u1ee7 l\u1ef1c RAP-219 trong \u0111i\u1ec1u tr\u1ecb \u0111\u1ed9ng kinh kh\u00e1ng thu\u1ed1c.<\/p>\n<p><strong>T\u1ea1i sao th\u00e1ng 9 l\u1ea1i quan tr\u1ecdng:<\/strong><br \/> L\u1ecbch s\u1eed cho th\u1ea5y c\u00e1c c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc th\u01b0\u1eddng c\u00f3 bi\u1ebfn \u0111\u1ed9ng gi\u00e1 l\u1edbn quanh c\u00e1c k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng. Khi Rapport c\u00f4ng b\u1ed1 k\u1ebft qu\u1ea3 qu\u00fd 2 v\u00e0o ng\u00e0y 7 th\u00e1ng 8 n\u0103m 2025, h\u1ecd \u0111\u00e3 v\u01b0\u1ee3t k\u1ef3 v\u1ecdng v\u1edbi m\u1ee9c l\u1ed7 0,75 USD tr\u00ean m\u1ed7i c\u1ed5 phi\u1ebfu so v\u1edbi m\u1ee9c l\u1ed7 d\u1ef1 ki\u1ebfn 0,85 USD (<a href=\"https:\/\/www.chartmill.com\/news\/RAPP\/Chartmill-32659-Rapport-Therapeutics-Inc-NASDAQRAPP-Reports-Narrower-Than-Expected-Q2-2025-Loss-Amid-Clinical-Progress\">Chartmill<\/a>). C\u1ed5 phi\u1ebfu t\u0103ng nh\u1eb9, nh\u01b0ng s\u1ef1 b\u00f9ng n\u1ed5 th\u1ef1c s\u1ef1 s\u1ebd \u0111\u1ebfn c\u00f9ng v\u1edbi d\u1eef li\u1ec7u th\u00e1ng 9.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/vt\/register\/\" class=\"po-cta-green\">B\u1eaft \u0111\u1ea7u giao d\u1ecbch\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng: T\u1eeb \u0110\u00e1y \u0110\u1ebfn Ph\u1ee5c H\u1ed3i<\/h2>\n<p>RAPP \u0111\u00e3 tr\u1ea3i qua m\u1ed9t chuy\u1ebfn t\u00e0u l\u01b0\u1ee3n si\u00eau t\u1ed1c! \u0110\u00e2y l\u00e0 nh\u1eefng g\u00ec \u0111\u00e3 x\u1ea3y ra trong 6 th\u00e1ng qua:<\/p>\n<p><strong>Th\u00e1ng 3 n\u0103m 2025:<\/strong> Ch\u1ea1m \u0111\u00e1y \u1edf m\u1ee9c <strong>6,43 USD<\/strong> \u2014 \u0111i\u1ec3m th\u1ea5p nh\u1ea5t tuy\u1ec7t \u0111\u1ed1i (<a href=\"https:\/\/www.tradingview.com\/symbols\/NASDAQ-RAPP\/\">TradingView<\/a>). Nh\u00e0 \u0111\u1ea7u t\u01b0 lo ng\u1ea1i v\u1ec1 vi\u1ec7c ti\u00eau ti\u1ec1n v\u00e0 ti\u1ebfn \u0111\u1ed9 th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng.<\/p>\n<p><strong>Th\u00e1ng 5-6 n\u0103m 2025:<\/strong> Ph\u1ee5c h\u1ed3i \u1ed5n \u0111\u1ecbnh l\u00ean kho\u1ea3ng <strong>8-12 USD<\/strong> khi c\u00f4ng ty c\u00f4ng b\u1ed1 d\u1eef li\u1ec7u an to\u00e0n Giai \u0111o\u1ea1n 1 t\u00edch c\u1ef1c v\u00e0 ti\u1ebfp t\u1ee5c tuy\u1ec3n d\u1ee5ng b\u1ec7nh nh\u00e2n th\u1eed nghi\u1ec7m.<\/p>\n<p><strong>Th\u00e1ng 8 n\u0103m 2025:<\/strong> \u1ed4n \u0111\u1ecbnh quanh m\u1ee9c <strong>14-16 USD<\/strong> sau k\u1ebft qu\u1ea3 qu\u00fd 2 t\u1ed1t h\u01a1n d\u1ef1 ki\u1ebfn v\u00e0 ho\u00e0n th\u00e0nh tuy\u1ec3n d\u1ee5ng th\u1eed nghi\u1ec7m Giai \u0111o\u1ea1n 2a.<\/p>\n<p><strong>Hi\u1ec7u su\u1ea5t 3 th\u00e1ng cho th\u1ea5y m\u1ee9c t\u0103ng \u1ea5n t\u01b0\u1ee3ng +34,26%<\/strong> (<a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/RAPP\/chart\/\">MarketBeat<\/a>), cho th\u1ea5y \u0111\u1ed9ng l\u1ef1c m\u1ea1nh m\u1ebd tr\u01b0\u1edbc s\u1ef1 ki\u1ec7n quan tr\u1ecdng th\u00e1ng 9.<\/p>\n<h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2>\n<ul>\n<li><strong>2025 (Cu\u1ed1i n\u0103m): 19-22 USD<\/strong> &#8211; N\u1ebfu k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m th\u00e1ng 9 t\u00edch c\u1ef1c, gi\u00e1 c\u00f3 th\u1ec3 t\u0103ng nhanh. \u01af\u1edbc t\u00ednh th\u1eadn tr\u1ecdng n\u1ebfu k\u1ebft qu\u1ea3 h\u1ed7n h\u1ee3p.<\/li>\n<li><strong>2026: 25-30 USD<\/strong> &#8211; Gi\u1ea3 s\u1eed d\u1eef li\u1ec7u Giai \u0111o\u1ea1n 2 th\u00e0nh c\u00f4ng d\u1eabn \u0111\u1ebfn m\u1edf r\u1ed9ng th\u1eed nghi\u1ec7m v\u00e0 th\u1ea3o lu\u1eadn h\u1ee3p t\u00e1c ti\u1ec1m n\u0103ng.<\/li>\n<li><strong>2028: 40-50 USD<\/strong> &#8211; Th\u1eddi \u0111i\u1ec3m c\u00f3 th\u1ec3 \u0111\u01b0\u1ee3c FDA ph\u00ea duy\u1ec7t ch\u1ec9 \u0111\u1ecbnh ch\u00ednh, t\u1ea1o ra gi\u00e1 tr\u1ecb \u0111\u00e1ng k\u1ec3.<\/li>\n<li><strong>2030: Tr\u00ean 60 USD<\/strong> &#8211; Nhi\u1ec1u ch\u1ec9 \u0111\u1ecbnh \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t v\u00e0 c\u00f3 th\u1ec3 tr\u1edf th\u00e0nh m\u1ee5c ti\u00eau mua l\u1ea1i c\u1ee7a c\u00e1c c\u00f4ng ty d\u01b0\u1ee3c l\u1edbn h\u01a1n.<\/li>\n<\/ul>\n<p><strong>K\u1ebft lu\u1eadn: MUA M\u1ea0NH<\/strong> d\u00e0nh cho nh\u00e0 \u0111\u1ea7u t\u01b0 ch\u1ecbu r\u1ee7i ro. S\u1ef1 ki\u1ec7n th\u00e1ng 9 c\u00f3 th\u1ec3 mang t\u00ednh chuy\u1ec3n \u0111\u1ed5i.<\/p>\n<h2>\u26a0\ufe0f R\u1ee7i Ro Ch\u00ednh v\u00e0 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2>\n<h3>R\u1ee7i ro c\u1ea7n c\u00e2n nh\u1eafc:<\/h3>\n<ul>\n<li><strong>Th\u1ea5t b\u1ea1i th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng<\/strong> &#8211; K\u1ebft qu\u1ea3 Giai \u0111o\u1ea1n 2 c\u00f3 th\u1ec3 g\u00e2y th\u1ea5t v\u1ecdng (gi\u1ea3m 40-50% c\u00f3 th\u1ec3 x\u1ea3y ra)<\/li>\n<li><strong>Ti\u00eau ti\u1ec1n nhanh<\/strong> &#8211; D\u1ef1 tr\u1eef ti\u1ec1n m\u1eb7t 260 tri\u1ec7u USD \u0111\u1ebfn n\u0103m 2026, nh\u01b0ng chi ph\u00ed R&#038;D \u0111ang t\u0103ng<\/li>\n<li><strong>R\u00e0o c\u1ea3n ph\u00e1p l\u00fd<\/strong> &#8211; Qu\u00e1 tr\u00ecnh ph\u00ea duy\u1ec7t FDA kh\u00f4ng th\u1ec3 \u0111o\u00e1n tr\u01b0\u1edbc<\/li>\n<li><strong>C\u1ea1nh tranh<\/strong> &#8211; C\u00e1c c\u00f4ng ty kh\u00e1c nh\u1eafm v\u00e0o c\u00e1c b\u1ec7nh th\u1ea7n kinh t\u01b0\u01a1ng t\u1ef1<\/li>\n<\/ul>\n<h3>T\u00edn hi\u1ec7u t\u00edch c\u1ef1c cho n\u0103m 2025:<\/h3>\n<ul>\n<li><strong>S\u1ef1 ki\u1ec7n th\u00e1ng 9<\/strong> &#8211; K\u1ebft qu\u1ea3 Giai \u0111o\u1ea1n 2 c\u00f3 th\u1ec3 th\u00fac \u0111\u1ea9y l\u1ee3i nhu\u1eadn tr\u00ean 100%<\/li>\n<li><strong>H\u1ed3 s\u01a1 an to\u00e0n s\u1ea1ch<\/strong> &#8211; Kh\u00f4ng c\u00f3 s\u1ef1 ki\u1ec7n b\u1ea5t l\u1ee3i nghi\u00eam tr\u1ecdng trong Giai \u0111o\u1ea1n 1 (<a href=\"https:\/\/www.stocktitan.net\/news\/RAPP\/rapport-therapeutics-reports-second-quarter-2025-financials-and-3wf9w5qi8j45.html\">StockTitan<\/a>)<\/li>\n<li><strong>Nhi\u1ec1u ch\u1ec9 \u0111\u1ecbnh<\/strong> &#8211; C\u00e1c ch\u01b0\u01a1ng tr\u00ecnh \u0111i\u1ec1u tr\u1ecb \u0111\u1ed9ng kinh, h\u01b0ng c\u1ea3m l\u01b0\u1ee1ng c\u1ef1c v\u00e0 \u0111au th\u1ea7n kinh<\/li>\n<li><strong>H\u1ed7 tr\u1ee3 m\u1ea1nh t\u1eeb c\u00e1c nh\u00e0 ph\u00e2n t\u00edch<\/strong> &#8211; M\u1ee5c ti\u00eau gi\u00e1 trung b\u00ecnh 33,67 USD (t\u0103ng 102%)<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Nh\u00e0 Giao D\u1ecbch M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2>\n<ol>\n<li><strong>B\u1eaft \u0111\u1ea7u nh\u1ecf<\/strong> &#8211; Ph\u00e2n b\u1ed5 kh\u00f4ng qu\u00e1 2-3% danh m\u1ee5c cho c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc r\u1ee7i ro cao<\/li>\n<li><strong>Ch\u1edd \u0111\u1ebfn th\u00e1ng 9<\/strong> &#8211; C\u00e2n nh\u1eafc mua sau khi c\u00f3 k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m \u0111\u1ec3 gi\u1ea3m r\u1ee7i ro<\/li>\n<li><strong>S\u1eed d\u1ee5ng l\u1ec7nh gi\u1edbi h\u1ea1n<\/strong> &#8211; \u0110\u1eb7t gi\u00e1 mua t\u1ed1i \u0111a \u0111\u1ec3 tr\u00e1nh tr\u1ea3 qu\u00e1 cao<\/li>\n<li><strong>G\u00f3c nh\u00ecn h\u00e0i h\u01b0\u1edbc<\/strong>: &#8220;Giao d\u1ecbch RAPP gi\u1ed1ng nh\u01b0 h\u1eb9n h\u00f2 th\u1eddi trung h\u1ecdc \u2014 ti\u1ec1m n\u0103ng h\u1ed3i h\u1ed9p nh\u01b0ng h\u00e3y chu\u1ea9n b\u1ecb cho nh\u1eefng c\u00fa s\u1ed1c c\u1ea3m x\u00fac. Gi\u1eef tr\u00e1i tim v\u00e0 danh m\u1ee5c \u0111\u1ea7u t\u01b0 c\u1ee7a b\u1ea1n an to\u00e0n!&#8221;<\/li>\n<\/ol>\n<h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Rapport Therapeutics (RAPP) &#8211; T\u1eebng B\u01b0\u1edbc<\/h2>\n<table>\n<thead>\n<tr>\n<th>B\u01b0\u1edbc<\/th>\n<th>H\u00e0nh \u0110\u1ed9ng<\/th>\n<th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Ch\u1ecdn n\u1ec1n t\u1ea3ng giao d\u1ecbch<\/td>\n<td>\u0110\u1ea3m b\u1ea3o n\u1ec1n t\u1ea3ng cung c\u1ea5p c\u1ed5 phi\u1ebfu NASDAQ v\u00e0 ph\u00ed h\u1ee3p l\u00fd<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>M\u1edf v\u00e0 n\u1ea1p ti\u1ec1n v\u00e0o t\u00e0i kho\u1ea3n<\/td>\n<td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n b\u1ea1n c\u1ea3m th\u1ea5y tho\u1ea3i m\u00e1i khi r\u1ee7i ro<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>T\u00ecm ki\u1ebfm &#8220;RAPP&#8221;<\/td>\n<td>S\u1eed d\u1ee5ng m\u00e3 ch\u1ee9ng kho\u00e1n, kh\u00f4ng ch\u1ec9 t\u00ean c\u00f4ng ty<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>\u0110\u1eb7t l\u1ec7nh gi\u1edbi h\u1ea1n<\/td>\n<td>Ch\u1ec9 \u0111\u1ecbnh m\u1ee9c gi\u00e1 14,50 USD ho\u1eb7c th\u1ea5p h\u01a1n \u0111\u1ec3 c\u00f3 \u0111i\u1ec3m v\u00e0o t\u1ed1t<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Xem l\u1ea1i v\u00e0 x\u00e1c nh\u1eadn<\/td>\n<td>Ki\u1ec3m tra ph\u00ed hoa h\u1ed3ng \u2014 m\u1ee5c ti\u00eau d\u01b0\u1edbi 1%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option Ph\u00f9 H\u1ee3p V\u1edbi Nh\u00e0 \u0110\u1ea7u T\u01b0 M\u1edbi<\/h2>\n<p>Pocket Option gi\u00fap \u0111\u1ea7u t\u01b0 c\u1ed5 phi\u1ebfu tr\u1edf n\u00ean d\u1ec5 ti\u1ebfp c\u1eadn cho m\u1ecdi ng\u01b0\u1eddi:<\/p>\n<ul>\n<li><strong>S\u1ed1 ti\u1ec1n g\u1eedi t\u1ed1i thi\u1ec3u: 5 USD<\/strong> &#8211; Ho\u00e0n h\u1ea3o \u0111\u1ec3 th\u1eed nghi\u1ec7m chi\u1ebfn l\u01b0\u1ee3c v\u1edbi r\u1ee7i ro th\u1ea5p<\/li>\n<li><strong>X\u00e1c minh nhanh nh\u01b0 ch\u1edbp<\/strong> &#8211; T\u1ea3i l\u00ean b\u1ea5t k\u1ef3 gi\u1ea5y t\u1edd t\u00f9y th\u00e2n n\u00e0o v\u00e0 b\u1eaft \u0111\u1ea7u giao d\u1ecbch trong v\u00e0i ph\u00fat<\/li>\n<li><strong>H\u01a1n 100 l\u1ef1a ch\u1ecdn r\u00fat ti\u1ec1n<\/strong> &#8211; T\u1eeb ti\u1ec1n \u0111i\u1ec7n t\u1eed \u0111\u1ebfn v\u00ed \u0111i\u1ec7n t\u1eed v\u00e0 th\u1ebb ng\u00e2n h\u00e0ng<\/li>\n<\/ul>\n<p>Giao di\u1ec7n th\u00e2n thi\u1ec7n v\u1edbi ng\u01b0\u1eddi d\u00f9ng v\u00e0 t\u00e0i nguy\u00ean gi\u00e1o d\u1ee5c c\u1ee7a n\u1ec1n t\u1ea3ng l\u00e0m cho n\u00f3 l\u00fd t\u01b0\u1edfng cho ng\u01b0\u1eddi m\u1edbi b\u1eaft \u0111\u1ea7u mu\u1ed1n th\u1eed s\u1ee9c \u0111\u1ea7u t\u01b0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc m\u00e0 kh\u00f4ng b\u1ecb qu\u00e1 t\u1ea3i.<\/p>\n<h2>\ud83c\udf0d Rapport Therapeutics N\u0103m 2025: Nh\u00e0 \u0110\u1ed5i M\u1edbi Trong L\u0129nh V\u1ef1c Th\u1ea7n Kinh<\/h2>\n<p>Rapport Therapeutics \u0111ang c\u00e1ch m\u1ea1ng h\u00f3a c\u00e1ch ch\u00fang ta \u0111i\u1ec1u tr\u1ecb c\u00e1c r\u1ed1i lo\u1ea1n n\u00e3o b\u1ed9. Kh\u00e1c v\u1edbi c\u00e1c lo\u1ea1i thu\u1ed1c truy\u1ec1n th\u1ed1ng \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn to\u00e0n b\u1ed9 n\u00e3o, c\u00f4ng ngh\u1ec7 RAP c\u1ee7a h\u1ecd nh\u1eafm v\u00e0o c\u00e1c v\u00f9ng c\u1ee5 th\u1ec3 \u2014 gi\u1ed1ng nh\u01b0 s\u1eed d\u1ee5ng s\u00fang b\u1eafn t\u1ec9a thay v\u00ec s\u00fang s\u0103n (<a href=\"https:\/\/www.globenewswire.com\/news-release\/2025\/06\/02\/3092291\/0\/en\/Rapport-Therapeutics-Hosts-Investor-and-Analyst-Day-Provides-Corporate-Updates.html\">GlobeNewswire<\/a>).<\/p>\n<p>Thu\u1ed1c ch\u1ee7 l\u1ef1c c\u1ee7a c\u00f4ng ty, RAP-219, \u0111\u00e3 ho\u00e0n th\u00e0nh tuy\u1ec3n d\u1ee5ng Giai \u0111o\u1ea1n 2a trong qu\u00fd 2 n\u0103m 2025 v\u00e0 c\u00f3 th\u1ec3 gi\u00fap h\u00e0ng tri\u1ec7u ng\u01b0\u1eddi m\u1eafc \u0111\u1ed9ng kinh kh\u00e1ng thu\u1ed1c. V\u1edbi 260,4 tri\u1ec7u USD ti\u1ec1n m\u1eb7t, h\u1ecd \u0111\u01b0\u1ee3c t\u00e0i tr\u1ee3 \u0111\u1ebfn n\u0103m 2026 \u2014 \u0111\u1ee7 ngu\u1ed3n l\u1ef1c \u0111\u1ec3 \u0111\u1ea1t c\u00e1c c\u1ed9t m\u1ed1c quan tr\u1ecdng.<\/p>\n<p><strong>S\u1ef1 th\u1eadt th\u00fa v\u1ecb:<\/strong> N\u0103m 2025, c\u00e1c nh\u00e0 khoa h\u1ecdc c\u1ee7a Rapport ph\u00e1t hi\u1ec7n c\u00f4ng ngh\u1ec7 c\u1ee7a h\u1ecd c\u00f3 th\u1ec3 \u0111\u01b0\u1ee3c \u00e1p d\u1ee5ng cho c\u00e1c r\u1ed1i lo\u1ea1n th\u00ednh gi\u00e1c, m\u1edf ra c\u00e1c h\u01b0\u1edbng \u0111i\u1ec1u tr\u1ecb ho\u00e0n to\u00e0n m\u1edbi ngo\u00e0i tr\u1ecdng t\u00e2m hi\u1ec7n t\u1ea1i v\u1ec1 \u0111\u1ed9ng kinh v\u00e0 \u0111au.<\/p>\n"},"faq":[{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 mua c\u1ed5 phi\u1ebfu Rapport Therapeutics (RAPP)?","answer":"B\u1ea1n c\u1ea7n ch\u1ecdn m\u1ed9t n\u1ec1n t\u1ea3ng giao d\u1ecbch h\u1ed7 tr\u1ee3 c\u1ed5 phi\u1ebfu NASDAQ, m\u1edf v\u00e0 n\u1ea1p ti\u1ec1n v\u00e0o t\u00e0i kho\u1ea3n, t\u00ecm m\u00e3 c\u1ed5 phi\u1ebfu RAPP, \u0111\u1eb7t l\u1ec7nh gi\u1edbi h\u1ea1n v\u1edbi gi\u00e1 ph\u00f9 h\u1ee3p v\u00e0 x\u00e1c nh\u1eadn giao d\u1ecbch."},{"question":"Gi\u00e1 c\u1ed5 phi\u1ebfu RAPP hi\u1ec7n t\u1ea1i l\u00e0 bao nhi\u00eau?","answer":"T\u00ednh \u0111\u1ebfn ng\u00e0y 29 th\u00e1ng 8 n\u0103m 2025, gi\u00e1 c\u1ed5 phi\u1ebfu RAPP l\u00e0 14,63 USD tr\u00ean s\u00e0n NASDAQ."},{"question":"Nh\u1eefng r\u1ee7i ro ch\u00ednh khi \u0111\u1ea7u t\u01b0 v\u00e0o RAPP l\u00e0 g\u00ec?","answer":"C\u00e1c r\u1ee7i ro bao g\u1ed3m th\u1ea5t b\u1ea1i th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng, ti\u00eau ti\u1ec1n nhanh, r\u00e0o c\u1ea3n ph\u00e1p l\u00fd t\u1eeb FDA v\u00e0 c\u1ea1nh tranh t\u1eeb c\u00e1c c\u00f4ng ty kh\u00e1c trong l\u0129nh v\u1ef1c th\u1ea7n kinh."},{"question":"Ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng c\u1ee7a RAPP trong t\u01b0\u01a1ng lai ra sao?","answer":"N\u1ebfu c\u00e1c th\u1eed nghi\u1ec7m th\u00e0nh c\u00f4ng, gi\u00e1 c\u1ed5 phi\u1ebfu c\u00f3 th\u1ec3 t\u0103ng l\u00ean 19-22 USD v\u00e0o cu\u1ed1i n\u0103m 2025, 25-30 USD n\u0103m 2026, 40-50 USD n\u0103m 2028 v\u00e0 tr\u00ean 60 USD v\u00e0o n\u0103m 2030."},{"question":"T\u00f4i l\u00e0 nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi, n\u00ean l\u00e0m g\u00ec khi \u0111\u1ea7u t\u01b0 v\u00e0o RAPP?","answer":"B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n nh\u1ecf, ch\u1edd k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m th\u00e1ng 9 \u0111\u1ec3 gi\u1ea3m r\u1ee7i ro, s\u1eed d\u1ee5ng l\u1ec7nh gi\u1edbi h\u1ea1n v\u00e0 kh\u00f4ng \u0111\u1ea7u t\u01b0 qu\u00e1 2-3% danh m\u1ee5c v\u00e0o c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc r\u1ee7i ro cao."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 mua c\u1ed5 phi\u1ebfu Rapport Therapeutics (RAPP)?","answer":"B\u1ea1n c\u1ea7n ch\u1ecdn m\u1ed9t n\u1ec1n t\u1ea3ng giao d\u1ecbch h\u1ed7 tr\u1ee3 c\u1ed5 phi\u1ebfu NASDAQ, m\u1edf v\u00e0 n\u1ea1p ti\u1ec1n v\u00e0o t\u00e0i kho\u1ea3n, t\u00ecm m\u00e3 c\u1ed5 phi\u1ebfu RAPP, \u0111\u1eb7t l\u1ec7nh gi\u1edbi h\u1ea1n v\u1edbi gi\u00e1 ph\u00f9 h\u1ee3p v\u00e0 x\u00e1c nh\u1eadn giao d\u1ecbch."},{"question":"Gi\u00e1 c\u1ed5 phi\u1ebfu RAPP hi\u1ec7n t\u1ea1i l\u00e0 bao nhi\u00eau?","answer":"T\u00ednh \u0111\u1ebfn ng\u00e0y 29 th\u00e1ng 8 n\u0103m 2025, gi\u00e1 c\u1ed5 phi\u1ebfu RAPP l\u00e0 14,63 USD tr\u00ean s\u00e0n NASDAQ."},{"question":"Nh\u1eefng r\u1ee7i ro ch\u00ednh khi \u0111\u1ea7u t\u01b0 v\u00e0o RAPP l\u00e0 g\u00ec?","answer":"C\u00e1c r\u1ee7i ro bao g\u1ed3m th\u1ea5t b\u1ea1i th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng, ti\u00eau ti\u1ec1n nhanh, r\u00e0o c\u1ea3n ph\u00e1p l\u00fd t\u1eeb FDA v\u00e0 c\u1ea1nh tranh t\u1eeb c\u00e1c c\u00f4ng ty kh\u00e1c trong l\u0129nh v\u1ef1c th\u1ea7n kinh."},{"question":"Ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng c\u1ee7a RAPP trong t\u01b0\u01a1ng lai ra sao?","answer":"N\u1ebfu c\u00e1c th\u1eed nghi\u1ec7m th\u00e0nh c\u00f4ng, gi\u00e1 c\u1ed5 phi\u1ebfu c\u00f3 th\u1ec3 t\u0103ng l\u00ean 19-22 USD v\u00e0o cu\u1ed1i n\u0103m 2025, 25-30 USD n\u0103m 2026, 40-50 USD n\u0103m 2028 v\u00e0 tr\u00ean 60 USD v\u00e0o n\u0103m 2030."},{"question":"T\u00f4i l\u00e0 nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi, n\u00ean l\u00e0m g\u00ec khi \u0111\u1ea7u t\u01b0 v\u00e0o RAPP?","answer":"B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n nh\u1ecf, ch\u1edd k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m th\u00e1ng 9 \u0111\u1ec3 gi\u1ea3m r\u1ee7i ro, s\u1eed d\u1ee5ng l\u1ec7nh gi\u1edbi h\u1ea1n v\u00e0 kh\u00f4ng \u0111\u1ea7u t\u01b0 qu\u00e1 2-3% danh m\u1ee5c v\u00e0o c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc r\u1ee7i ro cao."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>C\u00e1ch mua c\u1ed5 phi\u1ebfu Rapport Therapeutics, Inc. (RAPP) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Rapport Therapeutics, Inc. (RAPP)<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-rapport-therapeutics\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Rapport Therapeutics, Inc. (RAPP) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Rapport Therapeutics, Inc. (RAPP)\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-rapport-therapeutics\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-29T10:07:29+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-rapport-therapeutics\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-rapport-therapeutics\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Rapport Therapeutics, Inc. (RAPP) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Rapport Therapeutics, Inc. (RAPP)\",\"datePublished\":\"2025-08-29T10:07:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-rapport-therapeutics\/\"},\"wordCount\":23,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-rapport-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-rapport-therapeutics\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-rapport-therapeutics\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-rapport-therapeutics\/\",\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Rapport Therapeutics, Inc. (RAPP) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Rapport Therapeutics, Inc. (RAPP)\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-rapport-therapeutics\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-rapport-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp\",\"datePublished\":\"2025-08-29T10:07:29+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-rapport-therapeutics\/#breadcrumb\"},\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-rapport-therapeutics\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-rapport-therapeutics\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp\",\"width\":1408,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-rapport-therapeutics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/vt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Rapport Therapeutics, Inc. (RAPP) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Rapport Therapeutics, Inc. (RAPP)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vt-VT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Rapport Therapeutics, Inc. (RAPP) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Rapport Therapeutics, Inc. (RAPP)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-rapport-therapeutics\/","og_locale":"en_US","og_type":"article","og_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Rapport Therapeutics, Inc. (RAPP) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Rapport Therapeutics, Inc. (RAPP)","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-rapport-therapeutics\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-29T10:07:29+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-rapport-therapeutics\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-rapport-therapeutics\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Rapport Therapeutics, Inc. (RAPP) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Rapport Therapeutics, Inc. (RAPP)","datePublished":"2025-08-29T10:07:29+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-rapport-therapeutics\/"},"wordCount":23,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-rapport-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"vt-VT","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-rapport-therapeutics\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-rapport-therapeutics\/","url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-rapport-therapeutics\/","name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Rapport Therapeutics, Inc. (RAPP) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Rapport Therapeutics, Inc. (RAPP)","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-rapport-therapeutics\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-rapport-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp","datePublished":"2025-08-29T10:07:29+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-rapport-therapeutics\/#breadcrumb"},"inLanguage":"vt-VT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-rapport-therapeutics\/"]}]},{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-rapport-therapeutics\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp","width":1408,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-rapport-therapeutics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/vt\/"},{"@type":"ListItem","position":2,"name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Rapport Therapeutics, Inc. (RAPP) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Rapport Therapeutics, Inc. (RAPP)"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/vt\/#website","url":"https:\/\/pocketoption.com\/blog\/vt\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vt-VT"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"vt_VT","wpml_translations":{"pt_AA":{"locale":"pt_AA","id":357187,"slug":"how-to-buy-rapport-therapeutics","post_title":"Como comprar a\u00e7\u00f5es da Rapport Therapeutics, Inc. (RAPP) - Investimento em a\u00e7\u00f5es da Rapport Therapeutics, Inc. (RAPP)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-rapport-therapeutics\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/357191","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/comments?post=357191"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/357191\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media\/334036"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media?parent=357191"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/categories?post=357191"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/tags?post=357191"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}